NeuroFLiPP: Parametric PET of Neuroinflammation in Fatty Liver Disease
NCT06453915
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Positron Emission Tomography
Interventions
DRUG:
18F-DPA-714
DRUG:
18F-FDG
Sponsor
University of California, Davis